Epizyme (EPZM) Reports Q1 Loss of $0.39/Share

Epizyme (NASDAQ: EPZM) reported Q1 EPS of ($0.39), versus ($0.49) reported last year. Revenue for the quarter came in at $26.9 million, versus $25.6 million reported last year.

Financial Guidance

Following its March financing, and based on its current operating plan, Epizyme expects its cash runway to extend into at least the first quarter of 2021.

The company will not hold a conference call in conjunction with these results.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance